WARPAINT LONDON ORD 25P overview

Hardman & Co Research Hardman & Co Research: Warpaint London Plc (W7L): FY'18 sales: remains profitable despite weak UK market 24-Apr-2019 / 15:13 GMT/BST Hardman & Co Research: FY'18 sales: remains profitable despite weak UK market Warpaint, the UK-based colour cosmetics specialist, announced its full-year results for 2018. Revenue increased by 49.2% to £48.5m (FY'17: £32.5m); however, on a like-for-like basis, revenue was down 3.2% if we assume a full-year contribution from Retra in 2017. A...

Hardman & Co Research Hardman & Co Research: Warpaint London Plc (W7L): Trading update: softening UK market 01-Nov-2018 / 12:45 GMT/BST Hardman & Co: Trading update: softening UK market Warpaint has released a trading update for the year ending 31 December 2018. The company has prudently signalled that group sales for FY2018 are likely to be lower than previously indicated, in the range of £48m-£52m, with adjusted PBT of £8.5m-£10m. The company says that trading conditions in the UK remain...

Hardman & Co Research Hardman & Co Research: Warpaint London Plc (W7L): 1H'18 interims: delivering the results 04-Oct-2018 / 17:30 GMT/BST Hardman & Co: 1H'18 interims: delivering the results Warpaint's interim results for the six months ending June 2018 showed revenue up 38.7% to £18.4m (1H'17: £13.3m). The company's two divisions, own-brand and close-out, represented 84% and 16%, respectively, of the total revenue. Exports now account for 56% of sales, of which sales to the EU grew by 110%...

Hardman & Co Research Hardman & Co Research: Diurnal Group (DNL): First commercial revenues 04-Oct-2018 / 17:10 GMT/BST Hardman & Co: First commercial revenues Diurnal (DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead products target rare conditions where medical needs are currently unmet, with the aim of building a long-term 'Adrenal Franchise'. Following approval from the European Commission, Alkindi is being launched in key...

Hardman & Co Research Hardman & Co Research: Warpaint London PLC (W7L): Painting a bright future 13-Jun-2018 / 14:43 GMT/BST Hardman & Co Research: Painting a bright future Warpaint is a UK-based, colour cosmetics specialist that sells creative, designfocused and high-quality cosmetics at affordable prices. Warpaint'sflagship brand, W7, has established a loyal customer base, and brand awareness is growing rapidly. The company believes that, with Retra Holdings (Retra) now being well integrated...